Reid Robison, MD, MBA

Dr Robison is chief medical officer of Novamind; medical director for the Center for Change; and coordinating investigator for the Multidisciplinary Association for Psychedelic Studies’ phase 2 clinical trial examining MDMA-assisted psychotherapy for the treatment of eating disorders.